Sensus Healthcare Management
Management criteria checks 4/4
Sensus Healthcare's CEO is Joe Sardano, appointed in Jun 2010, has a tenure of 14.42 years. total yearly compensation is $687.60K, comprised of 65.4% salary and 34.6% bonuses, including company stock and options. directly owns 7.17% of the company’s shares, worth $8.09M. The average tenure of the management team and the board of directors is 3.3 years and 7.8 years respectively.
Key information
Joe Sardano
Chief executive officer
US$687.6k
Total compensation
| CEO salary percentage | 65.4% |
| CEO tenure | 14.4yrs |
| CEO ownership | 7.2% |
| Management average tenure | 3.3yrs |
| Board average tenure | 7.8yrs |
Recent management updates
Recent updates
Sensus Healthcare, Inc. (NASDAQ:SRTS) Doing What It Can To Lift Shares
Nov 12
At US$6.10, Is It Time To Put Sensus Healthcare, Inc. (NASDAQ:SRTS) On Your Watch List?
Oct 03Returns At Sensus Healthcare (NASDAQ:SRTS) Are On The Way Up
May 12Potential Upside For Sensus Healthcare, Inc. (NASDAQ:SRTS) Not Without Risk
Apr 16Sensus Healthcare, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Feb 11There's Been No Shortage Of Growth Recently For Sensus Healthcare's (NASDAQ:SRTS) Returns On Capital
Oct 17Sensus Healthcare (NASDAQ:SRTS) Might Have The Makings Of A Multi-Bagger
Jul 04Lacklustre Performance Is Driving Sensus Healthcare, Inc.'s (NASDAQ:SRTS) 26% Price Drop
Mar 14Do Sensus Healthcare's (NASDAQ:SRTS) Earnings Warrant Your Attention?
Mar 06Sensus Healthcare (NASDAQ:SRTS) Could Become A Multi-Bagger
Oct 11Sensus Healthcare Q2 GAAP EPS, revenue beats
Aug 04Sensus Healthcare: A Buy In Honor Of Skin Cancer Awareness Month
May 21Analysts Just Made A Captivating Upgrade To Their Sensus Healthcare, Inc. (NASDAQ:SRTS) Forecasts
May 11Investors Will Want Sensus Healthcare's (NASDAQ:SRTS) Growth In ROCE To Persist
Apr 29Sensus Healthcare's (NASDAQ:SRTS) Earnings Are Of Questionable Quality
Apr 01Are Investors Undervaluing Sensus Healthcare, Inc. (NASDAQ:SRTS) By 31%?
Dec 17CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$7m |
| Mar 31 2024 | n/a | n/a | US$5m |
| Dec 31 2023 | US$688k | US$450k | US$485k |
| Sep 30 2023 | n/a | n/a | -US$896k |
| Jun 30 2023 | n/a | n/a | US$2m |
| Mar 31 2023 | n/a | n/a | US$6m |
| Dec 31 2022 | US$754k | US$400k | US$24m |
| Sep 30 2022 | n/a | n/a | US$27m |
| Jun 30 2022 | n/a | n/a | US$25m |
| Mar 31 2022 | n/a | n/a | US$21m |
| Dec 31 2021 | US$628k | US$375k | US$4m |
| Sep 30 2021 | n/a | n/a | -US$181k |
| Jun 30 2021 | n/a | n/a | -US$2m |
| Mar 31 2021 | n/a | n/a | -US$4m |
| Dec 31 2020 | US$510k | US$375k | -US$7m |
| Sep 30 2020 | n/a | n/a | -US$7m |
| Jun 30 2020 | n/a | n/a | -US$6m |
| Mar 31 2020 | n/a | n/a | -US$3m |
| Dec 31 2019 | US$467k | US$375k | -US$2m |
| Sep 30 2019 | n/a | n/a | -US$3m |
| Jun 30 2019 | n/a | n/a | -US$2m |
| Mar 31 2019 | n/a | n/a | -US$3m |
| Dec 31 2018 | US$538k | US$360k | -US$2m |
| Sep 30 2018 | n/a | n/a | -US$3m |
| Jun 30 2018 | n/a | n/a | -US$3m |
| Mar 31 2018 | n/a | n/a | -US$3m |
| Dec 31 2017 | US$490k | US$324k | -US$4m |
Compensation vs Market: Joe's total compensation ($USD687.60K) is about average for companies of similar size in the US market ($USD647.72K).
Compensation vs Earnings: Joe's compensation has been consistent with company performance over the past year.
CEO
Joe Sardano (71 yo)
14.4yrs
Tenure
US$687,599
Compensation
Mr. Joseph C. Sardano, also known as Joe, serves as Director at BioFlorida Inc since August 2021. He Co-Founded Sensus Healthcare, Inc. in 2010 and has been its Chairman of the Board, Chief Executive Offic...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 14.4yrs | US$687.60k | 7.17% $ 8.1m | |
| President | 7.8yrs | US$452.53k | 0.46% $ 514.9k | |
| Chief Financial Officer | 4.8yrs | US$357.06k | 0.25% $ 276.9k | |
| Chief Operating Officer | 1.8yrs | no data | 0.060% $ 67.1k | |
| Chief Technology Officer | 1.8yrs | no data | 0.061% $ 68.8k | |
| Vice President of Marketing | 1.8yrs | no data | no data |
3.3yrs
Average Tenure
46yo
Average Age
Experienced Management: SRTS's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 14.4yrs | US$687.60k | 7.17% $ 8.1m | |
| President | less than a year | US$452.53k | 0.46% $ 514.9k | |
| Independent Director | 8.3yrs | US$75.00k | 0.28% $ 319.7k | |
| Member of Medical Advisory Board | 7.8yrs | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | 7.8yrs | no data | no data | |
| Member of Medical Advisory Board | 7.8yrs | no data | no data | |
| Independent Director | 9.1yrs | US$75.00k | 0.061% $ 68.8k | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | 7yrs | no data | no data | |
| Member of the Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data |
7.8yrs
Average Tenure
71yo
Average Age
Experienced Board: SRTS's board of directors are considered experienced (7.8 years average tenure).